Copolymeric nanofilm platform for controlled and localized therapeutic delivery

ACS Nano

Volumn 2, Issue 1, 2008, Pages 33-40

  Chow, Edward Kai Hua ^a   Pierstorff, Erik ^c   Cheng, Genhong ^a,b   Ho, Dean ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Northwestern University   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bionanotechnology; Block copolymer; Drug delivery; Inflammation; Nanomaterials; Nanomedicine

Indexed keywords

BIOMIMETICS; BLOCK COPOLYMERS; DRUG DELIVERY; NANOSTRUCTURED MATERIALS;

ANTI-INFLAMMATORY DRUG DELIVERY SYSTEM; DRUG ELUTION;

MEDICAL NANOTECHNOLOGY;

ANTIINFLAMMATORY AGENT; BIOMATERIAL; DEXAMETHASONE; DRUG CARRIER; NANOMATERIAL; POLYMER;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOCOMPATIBLE MATERIALS; CELL LINE; DEXAMETHASONE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MICE; NANOSTRUCTURES; POLYMERS;

EID: 42549116787     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn7000917     Document Type: Article

References (27)

1. Ho, D.; Chang, S.; Montemagno, C. D. Fabrication of Biofunctional Nanomaterials via Escherichia coli OmpF Protein Air/Water Interface Insertion/integration with Copolymeric Amphiphiles. Nanomedicine 2006, 2, 103-112.
2. Ho, D. Engineering Intelligent Materials for the Interrogation of Bio-Robotic Architectures and Regulatory Networks. IEEE Proc. IROS 2006, 18, 1849-1854.
3. Nardin, C.; Hirt, T.; Leukel, J.; Meier, W. Polymerized ABA Triblock Copolymer Vesicles. Langmuir 2000, 16, 1035-1041.
4. Discher, B. M.; Won, Y. Y.; Ege, D. S.; Lee, J. C.; Bates, F. S.; Discher, D. E.; Hammer, D. A. Polymersomes: Tough Vesicles Made from Diblock Copolymers. Science 1999, 284, 1143-1146.
5. Nardin, C.; Widmer, J.; Winterhalter, M.; Meier, W. Amphiphilic Block Copolymer Nanocontainers as Bioreactors. Eur. Phys. J. E 2001, 4, 403-410.
6. Nardin, C.; Thoeni, S.; Widmer, J.; Winterhalter, M.; Meier, W. Nanoreactors Based on (Polymerized) ABA-Triblock Copolymer Vesicles. Chem. Commun. 2000, 15, 1433-1434.
7. Discher, D. E.; Ahmed, F. Polymersomes. Annu. Rev. Biol. Eng. 2006, 8, 323-341.
8. Geng, Y.; Discher, D. E. Hydrolytic Shortening of Polycaprolactone-block-(Polyethylene Oxide) Worm Micelles. J. Am. Chem. Soc. 2005, 127, 12780-12781.
9. Ahmed, F, D.; Discher, D. E. Controlled Release from Polymersome Vesicles Blended with PEO-PLA or Related Hydrolysable Copolymer. J. Controlled Release 2004, 96, 37-53.
10. Discher, D. E.; Eisenberg, A. Polymer Vesicles. Science 2002, 297, 967-973.
11. Sigler, M.; Paul, T.; Grabitz, R. G. Biocompatibility Screening in Cardiovascular Implants. Z Kardiol. 2005, 94, 383-391.
12. Sutherland, K.; Mahoney, J. R.; Coury, A. J.; Eaton, J. W. Degradation of Biomaterials by Phagocyte-Derived Oxidants. J. Ciin. Invest. 1993, 92, 2360-2367.
13. Gerritsen, M.; Jansen, J. A.; Kros, A.; Vriezema, D. M.; Sommerdijk, N. A.; Nolte, R. J.; Lutterman, J. A., Van Hövell, S. W.; Van der Gaag, A. Influence of Inflammatory Cells and Serum on the Performance of Implantable Glucose Sensors. J. Biomed. Mater. 2001, 54, 69-75.
14. Gifford, R.; Batchelor, M. M.; Lee, Y.; Gokulrangan, G.; Meyerhoff, M. E.; Wilson, G. S. Mediation of In Vivo Glucose Sensor Inflammatory Response via Nitric Oxide Release. J. Biomed Mater. Res. A 2005, 75, 755-766.
15. Klueh, U.; Kreutzer, D. L. Murine Model of Implantable Glucose Sensors: A Novel Model for Glucose Sensor Development. Diabetes Technol. Ther. 2005, 7, 727-737.
16. Konttinen, Y. T.; Zhao, D.; Beklen, A.; Ma, G.; Takagi, M.; Kivelä-Rajamäki, M.; Ashammakhi, N.; Santavirta, S. The Microenvironment around Total Hip Replacement Prostheses. Clin. Orthop. Relat. Res. 2005, 430, 28-38.
17. Anderson, J. M. Inflammatory Response to Implants. ASAIO Trans. 1988, 34, 101-107.
18. Suska, F.; Gretzer, C.; Esposito, M.; Emanuelsson, L.; Wennerberg, A.; Tengvall, P.; Thomsen, P. In Vivo Cytokine Secretion and NF-kappaB Activation Around Titanium and Copper Implants. Biomaterials 2005, 26, 519-527.
19. Nakashima, Y.; Sun, D. H.; Trindade, M. C.; Maloney, W. J.; Goodman, S. B.; Schurman, D. J.; Smith, R. L. Signaling Pathways for Tumor Necrosis Factor-alpha and Interleukin-6 Expression in Human Macrophages Exposed to Titanium-Alloy Particulate Debris in vitro. J. Bone Joint Surg. Am. 1999, 81, 603-615.
20. Schreck, R.; Albermann, K.; Baeuerle, P. A. Nuclear Factor Kappa B: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review). Free Radical Res. Commun. 1992, 17, 221-237.
21. Pascual, G.; Glass, C. K. Nuclear Receptors Versus Inflammation: Mechanisms of Transrepression. Trends Endocrinol. Metab. 2006, 77, 321-327.
22. Luecke, H. F.; Yamamoto, K. R. The Glucocorticoid Receptor Blocks P-TEFb Recruitment by NFkappaB to Effect Promoter-Specific Transcriptional Repression. Genes Dev. 2005, 19, 1116-1127.
23. Ogawa, S.; Lozach, J.; Benner, C.; Pascual, G.; Tangirala, R. K.; Westin, S.; Hoffmann, A.; Subramaniam, S.; David, M.; Rosenfeld, M. G.; Glass, C. K. Molecular Determinants of Crosstalk Between Nuclear Receptors and Toll-Like Receptors. Cell 2005, 122, 707-721.
24. Zhou, X.; Gao, X. P.; Fan, J.; Liu, Q.; Anwar, K. N.; Frey, R. S.; Malik A. B. LPS Activation of Toll-Like Receptor 4 Signals CD11b/CD18 Expression in Neutraphils. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 288, L655-L662.
25. Burges, A.; Allmeling, A.; Krombach, F. Hyperoxia Induces Upregulation of CD11b and Amplifies LPS-induced TNF-alpha Release by Alveolar Macrophages. Eur. J. Med Res. 1997, 2, 149-154.
26. Rubel, C.; Miliani De Marval, P., Vermeulen, M.; Isturiz, M. A.; Palermo, M. S. Lipopolysaccharide Enhances FcgammaR-Dependent Functions In Vivo Through CD11b/CD18 Up-regulation. Immunology 1999, 97, 429-437.
27. Doyle, S.; Vaidya, S.; O'Connell, R.; Dadgostar, H.; Dempsey, P.; Wu, T.; Rao, G.; Sun, R.; Haberland, M.; Modlin, R.; Cheng, G. IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program. Immunity 2002, 17, 251-263.